Marvin Bradford Clevenger

Rocket Lab President Marvin Clevenger sold 3,500 shares at $146.67 on 2026-05-28 (total: $513,355.85), reducing stake to 474.0K shares.

Marvin Bradford Clevenger, President of Rocket Lab USA, Inc, executed a modest sale of 3,500 shares (3.5K shares) representing -0.7% of his pre-transaction holdings, at a price of $146.67 per share. The sale occurred when the stock stood 19.0% below its 52-week high of $151.00, despite strong recent momentum (30-day change: +55.3%, 90-day change: +74.5%). While the company remains unprofitable with a full-year net income of $-45.0M, it has achieved robust annual revenue growth of +38.0%, reaching $200.3M in the latest quarter. The magnitude and proportion of this sale are limited relative to Clevenger's remaining holdings of 473,975 shares (474.0K shares), and the absolute transaction size of $513,355.85 does not suggest a material shift in position.

Rocket Lab President Clevenger sold 15,549 shares for $2.2M at blended price of $142.57, retaining 477,475 shares post-sale.

Marvin Bradford Clevenger, President of Rocket Lab USA, Inc, executed 6 separate sales on 2026-05-26 totaling 15,549 shares for $2,216,875.19, with prices ranging from $139.41 to $144.13 and a blended average of $142.57. The sale reduced his holdings by 3.2% to 477,475 shares. This disposal occurs in a context of substantial recent stock appreciation: the stock has risen 88.4% over the past 30 days and 114.2% over 90 days, currently trading at $148.03 (near its 52-week high of $151.00). The company itself remains unprofitable on a full-year basis with net income of $-45,022,000.00 against quarterly revenue of $200,348,000.00, though it shows strong annual revenue growth of 38.0%. The multiple transactions at incrementally rising prices reflect a systematic execution pattern rather than a single decision point.